Finally, further other investigations showed that urinary GSTs predicted AKI progression or hospital mortality after cardiovascular surgery, where CM administration is correlated with kidney damage following an increase in urinary biomarkers [127,128,129]. The gene discussed is HPGDS; the disease is Nephropathy.